Navigation Links
Kerry Extends, Improves Small Business Innovation Program
Date:10/1/2007

Renewing Program Key for Massachusetts Firms

WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- Today the Senate passed the Department of Defense authorization bill with provisions secured by Senator John Kerry (D-Mass.) to extend the Small Business Innovation Research (SBIR) Program through 2010 and to increase the transition and commercialization of products developed by small firms. This critical extension will ensure that the thousands of firms that participate in the program each year, including many in Massachusetts, will not face the same delays and shut-downs of eight years ago. Massachusetts ranks second in the nation in SBIR awards, with small firms receiving more than $240 million in contracts in 2005. Over the life of the program, which Senator Edward M. Kennedy (D-Mass.) helped create, more than 10,200 Massachusetts small firms have received nearly $3 billion.

"Massachusetts small businesses are leading the country in developing technologies through the program that are helping to keep our troops safe on the battleground, improving our health care, and expanding our ability to combat global warming," said Kerry. "We need to keep this program strong, avoid any contracting delays or shut-downs, and provide more resources to rapidly transition the most promising technologies into weapons systems. I thank Senator Carl Levin and all the members of the Armed Services Committee for their leadership on these amendments and their support of this program."

"I'm pleased that the Senate has provided this extension to SBIR," said Senator Kennedy, a senior member of the Armed Services Committee. "Twenty-five years ago I helped to establish this program with Warren Rudman, and I'm glad that it will continue to offer essential support to our high-tech companies. Massachusetts is among the leading states in the nation in terms of the number and dollar value of SBIR awards, and I look forward to working with my colleagues to see that this program i
'/>"/>

SOURCE U.S. Senate Committee on Small Business & Entrepreneurship
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Collagen improves voice quality in Parkinsonism
3. Breakfast improves memory
4. A new hearing device improves hearing
5. Hormone replacement therapy improves sexual function
6. New therapy improves quality of life for cancer
7. Adding contrast improves ultrasounds ability to detect prostate cancer
8. Switching drugs regularly improves HIV treatment
9. Sage Improves Memory
10. Combination Therapy Found To Improves Stroke Recovery
11. Acupunture relieves pain and improves function in knee Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...ic and reconstructive surgeon has been given the g...ics committee of the Royal Free Hospital, London t...ing operations. However the Royal College of Surge...ing surgeons voicing their concerns about face tra...
...reported that they found H5N1 bird flu virus in sp... been detected// in the common, non-migratory bird...China's Hubei province tested excrement samples fr...break of bird flu in a county in Henan province in...
...ted disease known to be covert in most cases yet n...both sexes is now more discussed// about and peopl...to figures released this week in a report publishe...ows that one out of five women between the ages of...
...pear five times as likely as lean women to have po...s fertility and contributes to other// illnesses, ... Archives of Internal Medicine, one of the JAMA/Ar...drome occurs when the ovaries malfunction and leve...
Other Medicine News:Health News:Green Signal given to Full-Face Transplants 2Health News:Green Signal given to Full-Face Transplants 3Health News:Polycystic Ovary Syndrome More Prevalent in Overweight Women 2
(Date:10/6/2008)...n Concept of Other Product - Company,s Bioabsorbab...um, HONG KONG, Oct. 6 /- Data from m...ealing stent, OrbusNeich,s Genous Bio-engineered R...theter Cardiovascular,Therapeutics symposium, TCT ...., Ph.D., of the Academic Medical Center in,Amster...
(Date:10/3/2008)...JAVIK, Iceland, Oct. 3 /- d...e filing of an investigational new drug,(IND) appl...ule modulator,of phosphodiesterase 4 (PDE4), with ...pound is being developed as a new and potentially ...s and cognitive deficits associated,with Alzheimer...
(Date:10/2/2008)...S, October 2 /- Pharmaleads has obtai...authorization to perform a single,ascending dose P...,treatment of neuropathic pain., Neuropathic pain...ted,prevalence in the world,s population of up to ...y causes such as shingles, herpes, diabetes,antiv...
(Date:10/2/2008)...RD, England, October 2 /- Circassia L...on the fields of allergy and critical,care, today ... study of its,ToleroMune(R) technology in the fiel...ults achieved in an earlier phase II study, which ...e ToleroMune approach to allergy,desensitization.,...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Align Technology Inc Earns PACE Approval From Academy of General Dentistry 4112 1Align Technology Inc Earns PACE Approval From Academy of General Dentistry 4112 2Align Technology Inc Earns PACE Approval From Academy of General Dentistry 4112 3Shand Morahan 26 Co Inc and AVRECO Launch New Risk Management Program for Midwest Hospitals 4107 1Shand Morahan 26 Co Inc and AVRECO Launch New Risk Management Program for Midwest Hospitals 4107 2Shameful Votes Today on Childrens Health Care by Reps John Peterson Joe Pitts and Bill Shuster 4102 1Shameful Votes Today on Childrens Health Care by Reps John Peterson Joe Pitts and Bill Shuster 4102 2Coherent Inc to Webcast Fourth Fiscal Quarter 2007 Results 1355 1
...ed at the 12th Congress of European Hematology,Ass...PRNewswire-FirstCall/ --,Immunomedics, Inc. , a bi...clonal antibodies to treat cancer and other seriou... the 12th Congress,of EHA in Vienna, Austria, show...,s lymphoma (NHL) treated with a new,radioimmunoth...
....--(BUSINESS WIRE)--Jun 11, 2007 - Geron,Corporati...of,research studies indicating that GRNOPC1, the c...erapeutic for the treatment of,spinal cord injury,...., Presented by Geron scientist Ross Okamura at th...ing in San Diego, the findings,could mean that pat...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3
...us Camera are reciprocally calibrated, consistentl...y that can't be approximated with a third-party or...integrated synergy, calibration and measurement ac...ystem pixel for pixel, the FF 450plus Fundus Camer...
...laser from Carl Zeiss Meditec designed in particul...-cataract therapy) and iridotomy. However, the YAG...psulotomy and for IOL polishing. It's another mile...tice-oriented ophthalmic laser systems for photodi...
The Afinion HbA1c test and the fully automated Afinion Analyzer, give you reliable facts conveniently available when and where you need them. Advising the patient can be carried out with confidence.
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket.
Medicine Products: